Healthcare provider profile · identity verified

Mary E Carver, MSN

Nurse Practitioner · TERRELL, TX · NPI 1366463887

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	389	122
Rosuvastatin Calcium	Rosuvastatin Calcium	335	103
Levothyroxine Sodium	Levothyroxine Sodium	317	99
Lisinopril	Lisinopril	294	100
Hydrochlorothiazide	Hydrochlorothiazide	270	86
Atorvastatin Calcium	Atorvastatin Calcium	269	83
Losartan Potassium	Losartan Potassium	243	74
Gabapentin	Gabapentin	236	77
Pantoprazole Sodium	Pantoprazole Sodium	179	51
Tramadol Hcl	Tramadol Hcl	179	52
Omeprazole	Omeprazole	165	51
Escitalopram Oxalate	Escitalopram Oxalate	155	50
Simvastatin	Simvastatin	142	44
Potassium Chloride	Potassium Chloride	129	37
Sertraline Hcl	Sertraline Hcl	129	39
Albuterol Sulfate Hfa	Albuterol Sulfate	125	46
Metformin Hcl Er	Metformin Hcl	121	38
Tizanidine Hcl	Tizanidine Hcl	119	30
Metformin Hcl	Metformin Hcl	117	37
Tamsulosin Hcl	Tamsulosin Hcl	116	44
Glimepiride	Glimepiride	114	36
Metoprolol Succinate	Metoprolol Succinate	113	39
Methylprednisolone	Methylprednisolone	107	93
Meloxicam	Meloxicam	105	39
Pravastatin Sodium	Pravastatin Sodium	101	28
Olmesartan Medoxomil	Olmesartan Medoxomil	96	37
Furosemide	Furosemide	90	31
Duloxetine Hcl	Duloxetine Hcl	81	22
Citalopram Hbr	Citalopram Hydrobromide	75	25
Doxepin Hcl	Doxepin Hcl	74	22
Alprazolam	Alprazolam	72	22
Azithromycin	Azithromycin	71	65
Celecoxib	Celecoxib	71	29
Clopidogrel	Clopidogrel Bisulfate	71	27
Amitriptyline Hcl	Amitriptyline Hcl	68	22
Alendronate Sodium	Alendronate Sodium	67	21
Clonazepam	Clonazepam	67	16
Bupropion Xl	Bupropion Hcl	60	21
Acetaminophen-Codeine	Acetaminophen With Codeine	59	25
Zolpidem Tartrate	Zolpidem Tartrate	58	11
Carvedilol	Carvedilol	56	16
Allopurinol	Allopurinol	55	16
Eliquis	Apixaban	53	16
Lorazepam	Lorazepam	53	20
Trazodone Hcl	Trazodone Hcl	51	16
Azelastine Hcl	Azelastine Hcl	50	32
Montelukast Sodium	Montelukast Sodium	50	19
Jardiance	Empagliflozin	48	13
Hydroxyzine Hcl	Hydroxyzine Hcl	46	15
Metoprolol Tartrate	Metoprolol Tartrate	45	13
Amoxicillin	Amoxicillin	43	41
Estradiol	Estradiol	43	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	16
Temazepam	Temazepam	43	suppressed
Cefuroxime	Cefuroxime Axetil	41	35
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	13
Ipratropium Bromide	Ipratropium Bromide	40	14
Finasteride	Finasteride	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	12
Venlafaxine Hcl Er	Venlafaxine Hcl	37	11
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	34	11
Ezetimibe	Ezetimibe	34	13
Mounjaro	Tirzepatide	34	suppressed
Prednisone	Prednisone	32	20
Valsartan	Valsartan	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	31	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	30	suppressed
Ozempic	Semaglutide	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	22
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	11
Doxycycline Monohydrate	Doxycycline Monohydrate	28	25
Farxiga	Dapagliflozin Propanediol	27	suppressed
Ibuprofen	Ibuprofen	27	12
Fluticasone Propionate	Fluticasone Propionate	25	13
Pregabalin	Pregabalin	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	24	11
Fluconazole	Fluconazole	23	18
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Ramipril	Ramipril	22	suppressed
Atenolol	Atenolol	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	12
Ondansetron Odt	Ondansetron	19	17
Valacyclovir	Valacyclovir Hcl	19	11
Xarelto	Rivaroxaban	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Nystatin	Nystatin	17	12
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Cephalexin	Cephalexin	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	13
Methocarbamol	Methocarbamol	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Primidone	Primidone	16	suppressed
Raloxifene Hcl	Raloxifene Hcl	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Colesevelam Hcl	Colesevelam Hcl	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Tresiba Flextouch U-200	Insulin Degludec	14	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Etodolac	Etodolac	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Mupirocin	Mupirocin	12	12
Myrbetriq	Mirabegron	12	suppressed
Prolia	Denosumab	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Zaleplon	Zaleplon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error